This survey of recent research highlights two critical areas in the field of vaccination: the renal safety and effectiveness of COVID-19 vaccines in patients with Immunoglobulin A nephropathy (IgAN) and the ethnic disparities in routine childhood vaccination coverage in England. The first study, utilizing data from the global TriNetX collaborative networks, demonstrates that COVID-19 vaccination significantly reduces infection risks and complications in IgAN patients, despite a temporary decrease in renal function, which normalizes within nine months. This underscores the importance of vaccination in vulnerable populations while advocating for careful monitoring of renal function post-vaccination. The second study, drawing on electronic health records from the Clinical Practice Research Datalink (CPRD) Aurum, reveals persistent and widening ethnic disparities in childhood vaccination coverage in England, with children from minority ethnic groups, particularly those of Caribbean and other Black, African, and Caribbean backgrounds, having significantly lower vaccination rates compared to their White British counterparts. These findings call for urgent policy interventions to address these disparities. Together, these studies illuminate the multifaceted challenges and considerations in vaccination programs, from ensuring the safety and efficacy of vaccines in specific health conditions to addressing systemic inequities in vaccine coverage.